Latest France News

Little Green Pharma has terminated its planned sale and leaseback of its Western Australian production facility after failing to reach commercial terms, choosing to retain ownership without impacting operations.

Orezone Gold Corporation reported a robust 33% increase in revenue for FY2025, underpinned by higher gold prices and the start of hard rock production at Bomboré. The company also announced a strategic acquisition of the Casa Berardi gold mine in Canada.

Ramsay Health Care’s half-year results reveal a dramatic net profit rebound, driven by prior year impairments and solid growth in Australia and Europe. The company also announced a strategic acquisition and a proposed share distribution.

Nuix Limited has reported robust half-year results for 1H26, highlighted by a 148% increase in Nuix Neo Annualised Contract Value and a significant boost in profitability and cash flow.

Ramsay Health Care is set to simplify its corporate structure by distributing its majority stake in European healthcare provider Ramsay Santé directly to shareholders, enabling focused growth strategies for both entities.

Little Green Pharma has entered a $7.8 million sale and leaseback agreement for its Western Australia production site, aiming to fuel growth in Australia and Europe while maintaining operational control.

Orora Limited reported a statutory profit of $58.9 million for the half-year ended December 2025, driven by operational improvements despite significant restructuring costs. The company declared an interim dividend and announced a fresh share buy-back program.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.

Apollo Minerals welcomes a $2.8 million investment from Tribeca Investment Partners, marking a significant vote of confidence in its Couflens tungsten-gold project in southern France. This capital injection follows a recent $6.5 million raise and aims to accelerate exploration and development activities.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

Atlas Arteria confirms the extension of France’s temporary supplemental tax into 2026 but maintains its 40 cents per share distribution guidance, signalling confidence amid regulatory shifts.